The clinical management of bladder cancer (BC) has become an increasing challenge due
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …

Bladder cancer (BCa) is one of the 10 most common cancers with high morbidity and
mortality worldwide. Long noncoding RNAs (lncRNAs), a large class of noncoding RNA …

The limited effect of adjuvant therapy for advanced bladder cancer (BCa) leads to a poor
prognosis. Increasing evidence has shown that RNA N6-methyladenosine (m 6 A) …

Emerging evidence demonstrates that competing endogenous RNA (ceRNA) hypothesis
has played a role in molecular biological mechanisms of cancer occurrence and …

Background The large involvement of long non-coding RNAs (LncRNAs) in the biological
progression of numerous cancers has been reported. The function of lncRNA KCNQ1OT1 in …

Bladder cancer is a common disease associated with high rates of morbidity and mortality.
Although immunotherapy approaches such as adoptive T-cell therapy and immune …

Bladder cancer (BC) is the most common malignant tumor in the urinary system, and its early
diagnosis is conducive to improving clinical prognosis and prolonging overall survival time …

Endometriosis has a high recurrence rate after treatment, and there are no effective
recurrence predictors. LncRNA H19 has been found to be a predictor of the poor prognosis …

Programmed cell death-ligand 1 (PD-L1) is a glycoprotein that is expressed on the cell
surface of both hematopoietic and nonhematopoietic cells. PD-L1 play a role in the immune …

Statement of Retraction We, the Editors and Publisher of the journal Cell Cycle, have
retracted the following article: Hao Gao, **aofeng Li, Guangxi Zhan, Yong Zhu, **g Yu …